News | Harvard T.H. Chan School of Public Health

New TB vaccine could produce large health, economic benefits in LMICs

Introducing an effective new tuberculosis vaccine in low- and middle-income countries could lead to billions of dollars in potential health and economic benefits, according to a modeling study led by Harvard Chan School.

Making global health knowledge accessible

The Global Health Delivery Intensive program at Harvard T.H. Chan School of Public Health brings together mid-career professionals from around the world to gain skills and think through issues relating to improving health care delivery for patients.

Failure of tuberculosis treatment linked to bacterial resilience

Researchers have discovered a new form of altered drug susceptibility—dubbed antibiotic resilience—that enables Mycobacterium tuberculosis to survive antibiotic treatment.

Prenatal micronutrient supplementation could reduce noncommunicable diseases in children

Scaling up prenatal micronutrient supplementation could have population-wide benefits for the next generation.

Wafaie Fawzi, Vikram Patel, John Quackenbush elected to National Academy of Medicine

Harvard Chan School faculty members Wafaie Fawzi, Vikram Patel, and John Quackenbush were elected to the National Academy of Medicine.

Preparing for the next pandemic

Karl Lauterbach, Germany’s federal minister of health, discussed the G7 Pact for Pandemic Readiness at a Harvard Chan School seminar.

A multidisciplinary approach to eradicating malaria

Public health leaders from around the world gathered at Harvard University for a week-long course to learn the latest developments from experts and discuss new strategies for eradicating malaria.

Bringing heart and humanity to hematology

A hematology fellow from Australia, Eddie Cliff, MPH ’22, cares just as deeply about the well-being of his patients as he does about improving health systems as a whole. He’s also a writer published in the New York…